A case series involving the concomitant use of MicroMatrix® and Cytal® Wound Matrix 2-Layer with standard of care negative pressure wound therapy (NPWT) during the management of pilonidal wound healing.
This is a prospective case series examining the concomitant use of MicroMatrix® and Cytal® Wound Matrix 2-Layer with standard of care negative pressure wound therapy (NPWT) during the management of pilonidal wound healing. Wound healing will be evaluated at 2 weeks, 6 weeks, and 3 months. If subjects heal prior to the 3 month visit, wound healing will be documented at that visit. A maximum of ten subjects will be included in this series.
Study Type
OBSERVATIONAL
Enrollment
2
Porcine-derived extracellular matrix will be used in powder and 2-Layer wound sheet form in masses up to 1000 mg. Each product is intended for a one-time use only.
AdventHealth Tampa
Tampa, Florida, United States
Rate of Wound Closure
The study was terminated by Sponsor; no outcome measure data analyses were conducted.
Time frame: Up to 3 month visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.